Polycomb target genes are silenced in multiple myeloma.
Multiple myeloma (MM) is a genetically heterogeneous disease, which to date remains fatal. Finding a common mechanism for initiation and progression of MM continues to be challenging. By means of integrative genomics, we identified an underexpressed gene signature in MM patient cells compared to nor...
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2010-07-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC2901331?pdf=render |
| _version_ | 1830486360810586112 |
|---|---|
| author | Antonia Kalushkova Mårten Fryknäs Miguel Lemaire Charlotte Fristedt Prasoon Agarwal Maria Eriksson Sarah Deleu Peter Atadja Anders Osterborg Kenneth Nilsson Karin Vanderkerken Fredrik Oberg Helena Jernberg-Wiklund |
| author_facet | Antonia Kalushkova Mårten Fryknäs Miguel Lemaire Charlotte Fristedt Prasoon Agarwal Maria Eriksson Sarah Deleu Peter Atadja Anders Osterborg Kenneth Nilsson Karin Vanderkerken Fredrik Oberg Helena Jernberg-Wiklund |
| author_sort | Antonia Kalushkova |
| collection | DOAJ |
| description | Multiple myeloma (MM) is a genetically heterogeneous disease, which to date remains fatal. Finding a common mechanism for initiation and progression of MM continues to be challenging. By means of integrative genomics, we identified an underexpressed gene signature in MM patient cells compared to normal counterpart plasma cells. This profile was enriched for previously defined H3K27-tri-methylated genes, targets of the Polycomb group (PcG) proteins in human embryonic fibroblasts. Additionally, the silenced gene signature was more pronounced in ISS stage III MM compared to stage I and II. Using chromatin immunoprecipitation (ChIP) assay on purified CD138+ cells from four MM patients and on two MM cell lines, we found enrichment of H3K27me3 at genes selected from the profile. As the data implied that the Polycomb-targeted gene profile would be highly relevant for pharmacological treatment of MM, we used two compounds to chemically revert the H3K27-tri-methylation mediated gene silencing. The S-adenosylhomocysteine hydrolase inhibitor 3-Deazaneplanocin (DZNep) and the histone deacetylase inhibitor LBH589 (Panobinostat), reactivated the expression of genes repressed by H3K27me3, depleted cells from the PRC2 component EZH2 and induced apoptosis in human MM cell lines. In the immunocompetent 5T33MM in vivo model for MM, treatment with LBH589 resulted in gene upregulation, reduced tumor load and increased overall survival. Taken together, our results reveal a common gene signature in MM, mediated by gene silencing via the Polycomb repressor complex. The importance of the underexpressed gene profile in MM tumor initiation and progression should be subjected to further studies. |
| first_indexed | 2024-12-21T18:41:46Z |
| format | Article |
| id | doaj.art-1f3893bcdaf24c6d97ea336a9a5f5ad7 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-21T18:41:46Z |
| publishDate | 2010-07-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-1f3893bcdaf24c6d97ea336a9a5f5ad72022-12-21T18:53:59ZengPublic Library of Science (PLoS)PLoS ONE1932-62032010-07-0157e1148310.1371/journal.pone.0011483Polycomb target genes are silenced in multiple myeloma.Antonia KalushkovaMårten FryknäsMiguel LemaireCharlotte FristedtPrasoon AgarwalMaria ErikssonSarah DeleuPeter AtadjaAnders OsterborgKenneth NilssonKarin VanderkerkenFredrik ObergHelena Jernberg-WiklundMultiple myeloma (MM) is a genetically heterogeneous disease, which to date remains fatal. Finding a common mechanism for initiation and progression of MM continues to be challenging. By means of integrative genomics, we identified an underexpressed gene signature in MM patient cells compared to normal counterpart plasma cells. This profile was enriched for previously defined H3K27-tri-methylated genes, targets of the Polycomb group (PcG) proteins in human embryonic fibroblasts. Additionally, the silenced gene signature was more pronounced in ISS stage III MM compared to stage I and II. Using chromatin immunoprecipitation (ChIP) assay on purified CD138+ cells from four MM patients and on two MM cell lines, we found enrichment of H3K27me3 at genes selected from the profile. As the data implied that the Polycomb-targeted gene profile would be highly relevant for pharmacological treatment of MM, we used two compounds to chemically revert the H3K27-tri-methylation mediated gene silencing. The S-adenosylhomocysteine hydrolase inhibitor 3-Deazaneplanocin (DZNep) and the histone deacetylase inhibitor LBH589 (Panobinostat), reactivated the expression of genes repressed by H3K27me3, depleted cells from the PRC2 component EZH2 and induced apoptosis in human MM cell lines. In the immunocompetent 5T33MM in vivo model for MM, treatment with LBH589 resulted in gene upregulation, reduced tumor load and increased overall survival. Taken together, our results reveal a common gene signature in MM, mediated by gene silencing via the Polycomb repressor complex. The importance of the underexpressed gene profile in MM tumor initiation and progression should be subjected to further studies.http://europepmc.org/articles/PMC2901331?pdf=render |
| spellingShingle | Antonia Kalushkova Mårten Fryknäs Miguel Lemaire Charlotte Fristedt Prasoon Agarwal Maria Eriksson Sarah Deleu Peter Atadja Anders Osterborg Kenneth Nilsson Karin Vanderkerken Fredrik Oberg Helena Jernberg-Wiklund Polycomb target genes are silenced in multiple myeloma. PLoS ONE |
| title | Polycomb target genes are silenced in multiple myeloma. |
| title_full | Polycomb target genes are silenced in multiple myeloma. |
| title_fullStr | Polycomb target genes are silenced in multiple myeloma. |
| title_full_unstemmed | Polycomb target genes are silenced in multiple myeloma. |
| title_short | Polycomb target genes are silenced in multiple myeloma. |
| title_sort | polycomb target genes are silenced in multiple myeloma |
| url | http://europepmc.org/articles/PMC2901331?pdf=render |
| work_keys_str_mv | AT antoniakalushkova polycombtargetgenesaresilencedinmultiplemyeloma AT martenfryknas polycombtargetgenesaresilencedinmultiplemyeloma AT miguellemaire polycombtargetgenesaresilencedinmultiplemyeloma AT charlottefristedt polycombtargetgenesaresilencedinmultiplemyeloma AT prasoonagarwal polycombtargetgenesaresilencedinmultiplemyeloma AT mariaeriksson polycombtargetgenesaresilencedinmultiplemyeloma AT sarahdeleu polycombtargetgenesaresilencedinmultiplemyeloma AT peteratadja polycombtargetgenesaresilencedinmultiplemyeloma AT andersosterborg polycombtargetgenesaresilencedinmultiplemyeloma AT kennethnilsson polycombtargetgenesaresilencedinmultiplemyeloma AT karinvanderkerken polycombtargetgenesaresilencedinmultiplemyeloma AT fredrikoberg polycombtargetgenesaresilencedinmultiplemyeloma AT helenajernbergwiklund polycombtargetgenesaresilencedinmultiplemyeloma |